| Interactions between Microbiome and DME (MICBIO)
|
| Bacteria: Actinobacteria |
|---|
| Bifidobacterium adolescentis (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bifidobacterium adolescentis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bifidobacterium adolescentis co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bifidobacterium breve (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| Benzbromarone |
Click to Show/Hide the Detail |
| Drug ID |
DR0193
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bifidobacterium breve co-metabolize the drug Benzbromarone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bifidobacterium breve co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bifidobacterium breve co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bifidobacterium breve co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Bifidobacterium longum (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bifidobacterium longum co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bifidobacterium longum co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bifidobacterium ruminatum (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 7 Drugs Metabolized
|
| Bupropion |
Click to Show/Hide the Detail |
| Drug ID |
DR0247
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bifidobacterium ruminatum co-metabolize the drug Bupropion, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bifidobacterium ruminatum co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Irbesartan |
Click to Show/Hide the Detail |
| Drug ID |
DR0879
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bifidobacterium ruminatum co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Losartan potassium |
Click to Show/Hide the Detail |
| Drug ID |
DR0984
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bifidobacterium ruminatum co-metabolize the drug Losartan potassium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bifidobacterium ruminatum co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Oxaprozin |
Click to Show/Hide the Detail |
| Drug ID |
DR1212
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bifidobacterium ruminatum co-metabolize the drug Oxaprozin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Tolazamide |
Click to Show/Hide the Detail |
| Drug ID |
DR1611
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bifidobacterium ruminatum co-metabolize the drug Tolazamide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Collinsella aerofaciens (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Pitavastatin calcium |
Click to Show/Hide the Detail |
| Drug ID |
DR1306
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Collinsella aerofaciens co-metabolize the drug Pitavastatin calcium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Zidovudine |
Click to Show/Hide the Detail |
| Drug ID |
DR1729
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Collinsella aerofaciens co-metabolize the drug Zidovudine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [2] |
| Collinsella intestinalis (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Collinsella intestinalis co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Collinsella intestinalis co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Eggerthella lenta (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Dopamine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0532
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Eggerthella lenta co-metabolize the drug Dopamine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[12], [13] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Eggerthella lenta co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Mycobacterium tuberculosis (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Dextromethorphan hydrobromide |
Click to Show/Hide the Detail |
| Drug ID |
DR0476
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Mycobacterium tuberculosis co-metabolize the drug Dextromethorphan hydrobromide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[14], [15] |
| Nocardia farcinica (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Rifampicin |
Click to Show/Hide the Detail |
| Drug ID |
DR1420
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Nocardia farcinica co-metabolize the drug Rifampicin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [16] |
| Streptomyces avermitilis (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Coumarin |
Click to Show/Hide the Detail |
| Drug ID |
DR0386
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Streptomyces avermitilis co-metabolize the drug Coumarin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[17], [18], [19] |
| Diclofenac sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR0488
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Streptomyces avermitilis co-metabolize the drug Diclofenac sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[20], [18], [21] |
| Testosterone cypionate |
Click to Show/Hide the Detail |
| Drug ID |
DR1564
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Streptomyces avermitilis co-metabolize the drug Testosterone cypionate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[22], [23], [18] |
| Bacteria: Bacteroidetes |
|---|
| Alistipes indistinctus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| Cyclophosphamide |
Click to Show/Hide the Detail |
| Drug ID |
DR0391
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Alistipes indistinctus co-metabolize the drug Cyclophosphamide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Alistipes indistinctus co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Alistipes indistinctus co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Alistipes indistinctus co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bacteroides caccae (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides caccae co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Bacteroides cellulosilyticus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides cellulosilyticus co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides cellulosilyticus co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Tolazamide |
Click to Show/Hide the Detail |
| Drug ID |
DR1611
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides cellulosilyticus co-metabolize the drug Tolazamide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Bacteroides coprophilus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 7 Drugs Metabolized
|
| Carvedilol |
Click to Show/Hide the Detail |
| Drug ID |
DR0282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides coprophilus co-metabolize the drug Carvedilol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[26], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides coprophilus co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[27], [2] |
| Duloxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0554
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides coprophilus co-metabolize the drug Duloxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[28], [2] |
| Glipizide |
Click to Show/Hide the Detail |
| Drug ID |
DR0778
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides coprophilus co-metabolize the drug Glipizide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[29], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides coprophilus co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides coprophilus co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Tolazamide |
Click to Show/Hide the Detail |
| Drug ID |
DR1611
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides coprophilus co-metabolize the drug Tolazamide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Bacteroides dorei (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 20 Drugs Metabolized
|
| Carvedilol |
Click to Show/Hide the Detail |
| Drug ID |
DR0282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides dorei co-metabolize the drug Carvedilol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[26], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides dorei co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[27], [2] |
| Diclofenac sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR0488
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) metabolizes the drug Diclofenac sodium, and Bacteroides dorei further metabolizes its metabolite (Diclofenac glucuronide), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[20], [30] |
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides dorei co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [2] |
| Doxazosin |
Click to Show/Hide the Detail |
| Drug ID |
DR0542
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides dorei co-metabolize the drug Doxazosin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[31], [2] |
| Duloxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0554
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides dorei co-metabolize the drug Duloxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[28], [2] |
| Fluconazole |
Click to Show/Hide the Detail |
| Drug ID |
DR0704
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides dorei co-metabolize the drug Fluconazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[32], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides dorei co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Gliclazide |
Click to Show/Hide the Detail |
| Drug ID |
DR0776
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides dorei co-metabolize the drug Gliclazide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Glipizide |
Click to Show/Hide the Detail |
| Drug ID |
DR0778
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides dorei co-metabolize the drug Glipizide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[29], [2] |
| Irbesartan |
Click to Show/Hide the Detail |
| Drug ID |
DR0879
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides dorei co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Losartan potassium |
Click to Show/Hide the Detail |
| Drug ID |
DR0984
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides dorei co-metabolize the drug Losartan potassium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides dorei co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Oxaprozin |
Click to Show/Hide the Detail |
| Drug ID |
DR1212
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides dorei co-metabolize the drug Oxaprozin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Phenytoin |
Click to Show/Hide the Detail |
| Drug ID |
DR1282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides dorei co-metabolize the drug Phenytoin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[33], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides dorei co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Tolazamide |
Click to Show/Hide the Detail |
| Drug ID |
DR1611
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides dorei co-metabolize the drug Tolazamide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Valsartan |
Click to Show/Hide the Detail |
| Drug ID |
DR1668
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides dorei co-metabolize the drug Valsartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[34], [2] |
| Venlafaxine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1679
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides dorei co-metabolize the drug Venlafaxine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[35], [2] |
| Voriconazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1709
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides dorei co-metabolize the drug Voriconazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[36], [2] |
| Bacteroides eggerthii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 5 Drugs Metabolized
|
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides eggerthii co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[27], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides eggerthii co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Nateglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1132
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides eggerthii co-metabolize the drug Nateglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[37], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides eggerthii co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Tolazamide |
Click to Show/Hide the Detail |
| Drug ID |
DR1611
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides eggerthii co-metabolize the drug Tolazamide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Bacteroides finegoldii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides finegoldii co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bacteroides fragilis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 23 Drugs Metabolized
|
| Carvedilol |
Click to Show/Hide the Detail |
| Drug ID |
DR0282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides fragilis co-metabolize the drug Carvedilol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[26], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides fragilis co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[27], [2] |
| Cyclophosphamide |
Click to Show/Hide the Detail |
| Drug ID |
DR0391
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides fragilis co-metabolize the drug Cyclophosphamide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Etodolac |
Click to Show/Hide the Detail |
| Drug ID |
DR0666
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides fragilis co-metabolize the drug Etodolac, which can collectively affect efficacy, safety or bioavailability of this drug. |
[38], [2] |
| Fluconazole |
Click to Show/Hide the Detail |
| Drug ID |
DR0704
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides fragilis co-metabolize the drug Fluconazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[32], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides fragilis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Gliclazide |
Click to Show/Hide the Detail |
| Drug ID |
DR0776
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides fragilis co-metabolize the drug Gliclazide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Glipizide |
Click to Show/Hide the Detail |
| Drug ID |
DR0778
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides fragilis co-metabolize the drug Glipizide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[29], [2] |
| Indomethacin |
Click to Show/Hide the Detail |
| Drug ID |
DR0875
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides fragilis co-metabolize the drug Indomethacin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Irbesartan |
Click to Show/Hide the Detail |
| Drug ID |
DR0879
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides fragilis co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Losartan potassium |
Click to Show/Hide the Detail |
| Drug ID |
DR0984
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides fragilis co-metabolize the drug Losartan potassium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Metronidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1073
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides fragilis co-metabolize the drug Metronidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [39], [40] |
| Naftopidil |
Click to Show/Hide the Detail |
| Drug ID |
DR1124
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides fragilis co-metabolize the drug Naftopidil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[41], [2] |
| Naproxen |
Click to Show/Hide the Detail |
| Drug ID |
DR1130
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides fragilis co-metabolize the drug Naproxen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[42], [2] |
| Nateglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1132
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides fragilis co-metabolize the drug Nateglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[37], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides fragilis co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Oxaprozin |
Click to Show/Hide the Detail |
| Drug ID |
DR1212
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides fragilis co-metabolize the drug Oxaprozin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Rosuvastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR1445
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides fragilis co-metabolize the drug Rosuvastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[43], [2] |
| Tolazamide |
Click to Show/Hide the Detail |
| Drug ID |
DR1611
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides fragilis co-metabolize the drug Tolazamide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Tranilast |
Click to Show/Hide the Detail |
| Drug ID |
DR1628
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides fragilis co-metabolize the drug Tranilast, which can collectively affect efficacy, safety or bioavailability of this drug. |
[44], [2] |
| Valsartan |
Click to Show/Hide the Detail |
| Drug ID |
DR1668
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides fragilis co-metabolize the drug Valsartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[34], [2] |
| Voriconazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1709
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides fragilis co-metabolize the drug Voriconazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[36], [2] |
| Warfarin sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1717
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides fragilis co-metabolize the drug Warfarin sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[17], [2] |
| Bacteroides intestinalis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides intestinalis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides intestinalis co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Oxaprozin |
Click to Show/Hide the Detail |
| Drug ID |
DR1212
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides intestinalis co-metabolize the drug Oxaprozin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides intestinalis co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Bacteroides oleiciplenus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides oleiciplenus co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [45] |
| Bacteroides ovatus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 10 Drugs Metabolized
|
| Carvedilol |
Click to Show/Hide the Detail |
| Drug ID |
DR0282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides ovatus co-metabolize the drug Carvedilol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[26], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides ovatus co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[27], [2] |
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides ovatus co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [2] |
| Duloxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0554
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides ovatus co-metabolize the drug Duloxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[28], [2] |
| Fluconazole |
Click to Show/Hide the Detail |
| Drug ID |
DR0704
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides ovatus co-metabolize the drug Fluconazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[32], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides ovatus co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides ovatus co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Oxaprozin |
Click to Show/Hide the Detail |
| Drug ID |
DR1212
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides ovatus co-metabolize the drug Oxaprozin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Tolazamide |
Click to Show/Hide the Detail |
| Drug ID |
DR1611
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides ovatus co-metabolize the drug Tolazamide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Valsartan |
Click to Show/Hide the Detail |
| Drug ID |
DR1668
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides ovatus co-metabolize the drug Valsartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[34], [2] |
| Bacteroides sartorii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 19 Drugs Metabolized
|
| Carvedilol |
Click to Show/Hide the Detail |
| Drug ID |
DR0282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides sartorii co-metabolize the drug Carvedilol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[26], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides sartorii co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[27], [2] |
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides sartorii co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [2] |
| Duloxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0554
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides sartorii co-metabolize the drug Duloxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[28], [2] |
| Etodolac |
Click to Show/Hide the Detail |
| Drug ID |
DR0666
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides sartorii co-metabolize the drug Etodolac, which can collectively affect efficacy, safety or bioavailability of this drug. |
[38], [2] |
| Fluconazole |
Click to Show/Hide the Detail |
| Drug ID |
DR0704
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides sartorii co-metabolize the drug Fluconazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[32], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides sartorii co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Indomethacin |
Click to Show/Hide the Detail |
| Drug ID |
DR0875
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides sartorii co-metabolize the drug Indomethacin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Irbesartan |
Click to Show/Hide the Detail |
| Drug ID |
DR0879
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides sartorii co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Losartan potassium |
Click to Show/Hide the Detail |
| Drug ID |
DR0984
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides sartorii co-metabolize the drug Losartan potassium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Naproxen |
Click to Show/Hide the Detail |
| Drug ID |
DR1130
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides sartorii co-metabolize the drug Naproxen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[42], [2] |
| Nateglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1132
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides sartorii co-metabolize the drug Nateglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[37], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides sartorii co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Oxaprozin |
Click to Show/Hide the Detail |
| Drug ID |
DR1212
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides sartorii co-metabolize the drug Oxaprozin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Phenytoin |
Click to Show/Hide the Detail |
| Drug ID |
DR1282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides sartorii co-metabolize the drug Phenytoin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[33], [2] |
| Tolazamide |
Click to Show/Hide the Detail |
| Drug ID |
DR1611
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides sartorii co-metabolize the drug Tolazamide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Valsartan |
Click to Show/Hide the Detail |
| Drug ID |
DR1668
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides sartorii co-metabolize the drug Valsartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[34], [2] |
| Venlafaxine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1679
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides sartorii co-metabolize the drug Venlafaxine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[35], [2] |
| Voriconazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1709
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides sartorii co-metabolize the drug Voriconazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[36], [2] |
| Bacteroides stercoris (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 8 Drugs Metabolized
|
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides stercoris co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[27], [2] |
| Fluconazole |
Click to Show/Hide the Detail |
| Drug ID |
DR0704
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides stercoris co-metabolize the drug Fluconazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[32], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides stercoris co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Indomethacin |
Click to Show/Hide the Detail |
| Drug ID |
DR0875
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides stercoris co-metabolize the drug Indomethacin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides stercoris co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Oxaprozin |
Click to Show/Hide the Detail |
| Drug ID |
DR1212
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides stercoris co-metabolize the drug Oxaprozin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Tolazamide |
Click to Show/Hide the Detail |
| Drug ID |
DR1611
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides stercoris co-metabolize the drug Tolazamide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Venlafaxine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1679
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides stercoris co-metabolize the drug Venlafaxine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[35], [2] |
| Bacteroides thetaiotaomicron (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 17 Drugs Metabolized
|
| Carvedilol |
Click to Show/Hide the Detail |
| Drug ID |
DR0282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides thetaiotaomicron co-metabolize the drug Carvedilol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[26], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides thetaiotaomicron co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[27], [2] |
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides thetaiotaomicron co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [2] |
| Etodolac |
Click to Show/Hide the Detail |
| Drug ID |
DR0666
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides thetaiotaomicron co-metabolize the drug Etodolac, which can collectively affect efficacy, safety or bioavailability of this drug. |
[38], [2] |
| Fluconazole |
Click to Show/Hide the Detail |
| Drug ID |
DR0704
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides thetaiotaomicron co-metabolize the drug Fluconazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[32], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides thetaiotaomicron co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Gliclazide |
Click to Show/Hide the Detail |
| Drug ID |
DR0776
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides thetaiotaomicron co-metabolize the drug Gliclazide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Indomethacin |
Click to Show/Hide the Detail |
| Drug ID |
DR0875
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides thetaiotaomicron co-metabolize the drug Indomethacin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Irbesartan |
Click to Show/Hide the Detail |
| Drug ID |
DR0879
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides thetaiotaomicron co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Naproxen |
Click to Show/Hide the Detail |
| Drug ID |
DR1130
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides thetaiotaomicron co-metabolize the drug Naproxen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[42], [2] |
| Nateglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1132
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides thetaiotaomicron co-metabolize the drug Nateglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[37], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides thetaiotaomicron co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Oxaprozin |
Click to Show/Hide the Detail |
| Drug ID |
DR1212
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides thetaiotaomicron co-metabolize the drug Oxaprozin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Tolazamide |
Click to Show/Hide the Detail |
| Drug ID |
DR1611
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides thetaiotaomicron co-metabolize the drug Tolazamide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Tranilast |
Click to Show/Hide the Detail |
| Drug ID |
DR1628
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides thetaiotaomicron co-metabolize the drug Tranilast, which can collectively affect efficacy, safety or bioavailability of this drug. |
[44], [2] |
| Valsartan |
Click to Show/Hide the Detail |
| Drug ID |
DR1668
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides thetaiotaomicron co-metabolize the drug Valsartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[34], [2] |
| Voriconazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1709
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides thetaiotaomicron co-metabolize the drug Voriconazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[36], [2] |
| Bacteroides uniformis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides uniformis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides uniformis co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bacteroides vulgatus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 19 Drugs Metabolized
|
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides vulgatus co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[27], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides vulgatus co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Gliclazide |
Click to Show/Hide the Detail |
| Drug ID |
DR0776
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides vulgatus co-metabolize the drug Gliclazide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Imatinib mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0858
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides vulgatus co-metabolize the drug Imatinib mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[46], [2] |
| Indomethacin |
Click to Show/Hide the Detail |
| Drug ID |
DR0875
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) metabolizes the drug Indomethacin, and Bacteroides vulgatus further metabolizes its metabolite (Indomethacin glucuronide), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[5], [47] |
| Irbesartan |
Click to Show/Hide the Detail |
| Drug ID |
DR0879
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides vulgatus co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Losartan potassium |
Click to Show/Hide the Detail |
| Drug ID |
DR0984
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides vulgatus co-metabolize the drug Losartan potassium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Naproxen |
Click to Show/Hide the Detail |
| Drug ID |
DR1130
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides vulgatus co-metabolize the drug Naproxen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[42], [2] |
| Nateglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1132
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides vulgatus co-metabolize the drug Nateglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[37], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides vulgatus co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Oxaprozin |
Click to Show/Hide the Detail |
| Drug ID |
DR1212
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides vulgatus co-metabolize the drug Oxaprozin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Phenytoin |
Click to Show/Hide the Detail |
| Drug ID |
DR1282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides vulgatus co-metabolize the drug Phenytoin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[33], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides vulgatus co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Tolazamide |
Click to Show/Hide the Detail |
| Drug ID |
DR1611
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides vulgatus co-metabolize the drug Tolazamide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Valsartan |
Click to Show/Hide the Detail |
| Drug ID |
DR1668
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides vulgatus co-metabolize the drug Valsartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[34], [2] |
| Venlafaxine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1679
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides vulgatus co-metabolize the drug Venlafaxine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[35], [2] |
| Verapamil hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1681
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides vulgatus co-metabolize the drug Verapamil hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [2] |
| Voriconazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1709
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides vulgatus co-metabolize the drug Voriconazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[36], [2] |
| Warfarin sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1717
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides vulgatus co-metabolize the drug Warfarin sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[17], [2] |
| Bacteroides xylanisolvens (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 17 Drugs Metabolized
|
| Carvedilol |
Click to Show/Hide the Detail |
| Drug ID |
DR0282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides xylanisolvens co-metabolize the drug Carvedilol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[26], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides xylanisolvens co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[27], [2] |
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides xylanisolvens co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [2] |
| Etodolac |
Click to Show/Hide the Detail |
| Drug ID |
DR0666
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides xylanisolvens co-metabolize the drug Etodolac, which can collectively affect efficacy, safety or bioavailability of this drug. |
[38], [2] |
| Fluconazole |
Click to Show/Hide the Detail |
| Drug ID |
DR0704
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides xylanisolvens co-metabolize the drug Fluconazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[32], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides xylanisolvens co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Indomethacin |
Click to Show/Hide the Detail |
| Drug ID |
DR0875
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides xylanisolvens co-metabolize the drug Indomethacin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Irbesartan |
Click to Show/Hide the Detail |
| Drug ID |
DR0879
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides xylanisolvens co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Losartan potassium |
Click to Show/Hide the Detail |
| Drug ID |
DR0984
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides xylanisolvens co-metabolize the drug Losartan potassium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Naproxen |
Click to Show/Hide the Detail |
| Drug ID |
DR1130
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides xylanisolvens co-metabolize the drug Naproxen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[42], [2] |
| Nateglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1132
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides xylanisolvens co-metabolize the drug Nateglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[37], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides xylanisolvens co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Oxaprozin |
Click to Show/Hide the Detail |
| Drug ID |
DR1212
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides xylanisolvens co-metabolize the drug Oxaprozin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Phenytoin |
Click to Show/Hide the Detail |
| Drug ID |
DR1282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides xylanisolvens co-metabolize the drug Phenytoin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[33], [2] |
| Tolazamide |
Click to Show/Hide the Detail |
| Drug ID |
DR1611
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides xylanisolvens co-metabolize the drug Tolazamide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Valsartan |
Click to Show/Hide the Detail |
| Drug ID |
DR1668
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides xylanisolvens co-metabolize the drug Valsartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[34], [2] |
| Voriconazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1709
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides xylanisolvens co-metabolize the drug Voriconazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[36], [2] |
| Odoribacter splanchnicus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 17 Drugs Metabolized
|
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Odoribacter splanchnicus co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[27], [2] |
| Etodolac |
Click to Show/Hide the Detail |
| Drug ID |
DR0666
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Odoribacter splanchnicus co-metabolize the drug Etodolac, which can collectively affect efficacy, safety or bioavailability of this drug. |
[38], [2] |
| Fluconazole |
Click to Show/Hide the Detail |
| Drug ID |
DR0704
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Odoribacter splanchnicus co-metabolize the drug Fluconazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[32], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Odoribacter splanchnicus co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Gliclazide |
Click to Show/Hide the Detail |
| Drug ID |
DR0776
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Odoribacter splanchnicus co-metabolize the drug Gliclazide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Glipizide |
Click to Show/Hide the Detail |
| Drug ID |
DR0778
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Odoribacter splanchnicus co-metabolize the drug Glipizide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[29], [2] |
| Indomethacin |
Click to Show/Hide the Detail |
| Drug ID |
DR0875
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Odoribacter splanchnicus co-metabolize the drug Indomethacin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Irbesartan |
Click to Show/Hide the Detail |
| Drug ID |
DR0879
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Odoribacter splanchnicus co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Losartan potassium |
Click to Show/Hide the Detail |
| Drug ID |
DR0984
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Odoribacter splanchnicus co-metabolize the drug Losartan potassium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Naproxen |
Click to Show/Hide the Detail |
| Drug ID |
DR1130
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Odoribacter splanchnicus co-metabolize the drug Naproxen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[42], [2] |
| Nateglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1132
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Odoribacter splanchnicus co-metabolize the drug Nateglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[37], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Odoribacter splanchnicus co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Oxaprozin |
Click to Show/Hide the Detail |
| Drug ID |
DR1212
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Odoribacter splanchnicus co-metabolize the drug Oxaprozin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Odoribacter splanchnicus co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Tolazamide |
Click to Show/Hide the Detail |
| Drug ID |
DR1611
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Odoribacter splanchnicus co-metabolize the drug Tolazamide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Valsartan |
Click to Show/Hide the Detail |
| Drug ID |
DR1668
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Odoribacter splanchnicus co-metabolize the drug Valsartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[34], [2] |
| Voriconazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1709
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Odoribacter splanchnicus co-metabolize the drug Voriconazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[36], [2] |
| Parabacteroides distasonis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 12 Drugs Metabolized
|
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Parabacteroides distasonis co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[27], [2] |
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Parabacteroides distasonis co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Parabacteroides distasonis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Gliclazide |
Click to Show/Hide the Detail |
| Drug ID |
DR0776
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Parabacteroides distasonis co-metabolize the drug Gliclazide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Losartan potassium |
Click to Show/Hide the Detail |
| Drug ID |
DR0984
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Parabacteroides distasonis co-metabolize the drug Losartan potassium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Naproxen |
Click to Show/Hide the Detail |
| Drug ID |
DR1130
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Parabacteroides distasonis co-metabolize the drug Naproxen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[42], [2] |
| Nateglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1132
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Parabacteroides distasonis co-metabolize the drug Nateglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[37], [2] |
| Oxaprozin |
Click to Show/Hide the Detail |
| Drug ID |
DR1212
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Parabacteroides distasonis co-metabolize the drug Oxaprozin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Phenytoin |
Click to Show/Hide the Detail |
| Drug ID |
DR1282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Parabacteroides distasonis co-metabolize the drug Phenytoin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[33], [2] |
| Tolazamide |
Click to Show/Hide the Detail |
| Drug ID |
DR1611
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Parabacteroides distasonis co-metabolize the drug Tolazamide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Valsartan |
Click to Show/Hide the Detail |
| Drug ID |
DR1668
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Parabacteroides distasonis co-metabolize the drug Valsartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[34], [2] |
| Voriconazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1709
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Parabacteroides distasonis co-metabolize the drug Voriconazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[36], [2] |
| Parabacteroides johnsonii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 9 Drugs Metabolized
|
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Parabacteroides johnsonii co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[27], [2] |
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Parabacteroides johnsonii co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [2] |
| Estrone sulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0650
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Parabacteroides johnsonii co-metabolize the drug Estrone sulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[17], [48] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Parabacteroides johnsonii co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Irbesartan |
Click to Show/Hide the Detail |
| Drug ID |
DR0879
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Parabacteroides johnsonii co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Losartan potassium |
Click to Show/Hide the Detail |
| Drug ID |
DR0984
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Parabacteroides johnsonii co-metabolize the drug Losartan potassium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Parabacteroides johnsonii co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Parabacteroides johnsonii co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Tolazamide |
Click to Show/Hide the Detail |
| Drug ID |
DR1611
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Parabacteroides johnsonii co-metabolize the drug Tolazamide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Parabacteroides merdae (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 7 Drugs Metabolized
|
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Parabacteroides merdae co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[27], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Parabacteroides merdae co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Indomethacin |
Click to Show/Hide the Detail |
| Drug ID |
DR0875
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Parabacteroides merdae co-metabolize the drug Indomethacin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Irbesartan |
Click to Show/Hide the Detail |
| Drug ID |
DR0879
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Parabacteroides merdae co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Losartan potassium |
Click to Show/Hide the Detail |
| Drug ID |
DR0984
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Parabacteroides merdae co-metabolize the drug Losartan potassium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Nateglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1132
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Parabacteroides merdae co-metabolize the drug Nateglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[37], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Parabacteroides merdae co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Prevotella buccae (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Estrone sulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0650
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Prevotella buccae co-metabolize the drug Estrone sulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[17], [49], [50] |
| Prevotella copri (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 6 Drugs Metabolized
|
| Aspirin |
Click to Show/Hide the Detail |
| Drug ID |
DR1749
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Prevotella copri co-metabolize the drug Aspirin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[51], [52] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Prevotella copri co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Prevotella copri co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Prevotella copri co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Tolazamide |
Click to Show/Hide the Detail |
| Drug ID |
DR1611
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Prevotella copri co-metabolize the drug Tolazamide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Valsartan |
Click to Show/Hide the Detail |
| Drug ID |
DR1668
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Prevotella copri co-metabolize the drug Valsartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[34], [2] |
| Bacteria: Firmicutes |
|---|
| Anaerobutyricum hallii (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Anaerobutyricum hallii co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Anaerobutyricum hallii co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Anaerobutyricum hallii co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Anaerococcus hydrogenalis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Anaerococcus hydrogenalis co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Anaerococcus hydrogenalis co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Zidovudine |
Click to Show/Hide the Detail |
| Drug ID |
DR1729
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Anaerococcus hydrogenalis co-metabolize the drug Zidovudine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [2] |
| Anaerostipes hadrus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Imatinib mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0858
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Anaerostipes hadrus co-metabolize the drug Imatinib mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[46], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Anaerostipes hadrus co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Anaerotruncus colihominis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Anaerotruncus colihominis co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Anaerotruncus colihominis co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Bacillus megaterium (firmicutes) |
Click to Show/Hide the Full List of Drugs: 6 Drugs Metabolized
|
| Acetaminophen |
Click to Show/Hide the Detail |
| Drug ID |
DR0037
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacillus megaterium co-metabolize the drug Acetaminophen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [53] |
| Dextromethorphan hydrobromide |
Click to Show/Hide the Detail |
| Drug ID |
DR0476
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacillus megaterium co-metabolize the drug Dextromethorphan hydrobromide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[14], [53] |
| Diclofenac sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR0488
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacillus megaterium co-metabolize the drug Diclofenac sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[20], [54] |
| Mefenamic acid |
Click to Show/Hide the Detail |
| Drug ID |
DR1014
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacillus megaterium co-metabolize the drug Mefenamic acid, which can collectively affect efficacy, safety or bioavailability of this drug. |
[55], [54] |
| Progesterone |
Click to Show/Hide the Detail |
| Drug ID |
DR1346
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacillus megaterium co-metabolize the drug Progesterone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[56], [57] |
| Testosterone cypionate |
Click to Show/Hide the Detail |
| Drug ID |
DR1564
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacillus megaterium co-metabolize the drug Testosterone cypionate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[22], [57], [58] |
| Bacteroides pectinophilus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides pectinophilus co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides pectinophilus co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides pectinophilus co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Tolazamide |
Click to Show/Hide the Detail |
| Drug ID |
DR1611
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Bacteroides pectinophilus co-metabolize the drug Tolazamide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Blautia hansenii (firmicutes) |
Click to Show/Hide the Full List of Drugs: 18 Drugs Metabolized
|
| Carvedilol |
Click to Show/Hide the Detail |
| Drug ID |
DR0282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Blautia hansenii co-metabolize the drug Carvedilol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[26], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Blautia hansenii co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[27], [2] |
| Cyclophosphamide |
Click to Show/Hide the Detail |
| Drug ID |
DR0391
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Blautia hansenii co-metabolize the drug Cyclophosphamide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Blautia hansenii co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [2] |
| Doxazosin |
Click to Show/Hide the Detail |
| Drug ID |
DR0542
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Blautia hansenii co-metabolize the drug Doxazosin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[31], [2] |
| Duloxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0554
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Blautia hansenii co-metabolize the drug Duloxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[28], [2] |
| Etodolac |
Click to Show/Hide the Detail |
| Drug ID |
DR0666
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Blautia hansenii co-metabolize the drug Etodolac, which can collectively affect efficacy, safety or bioavailability of this drug. |
[38], [2] |
| Fluconazole |
Click to Show/Hide the Detail |
| Drug ID |
DR0704
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Blautia hansenii co-metabolize the drug Fluconazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[32], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Blautia hansenii co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Irbesartan |
Click to Show/Hide the Detail |
| Drug ID |
DR0879
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Blautia hansenii co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Nateglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1132
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Blautia hansenii co-metabolize the drug Nateglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[37], [2] |
| Nevirapine |
Click to Show/Hide the Detail |
| Drug ID |
DR1142
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Blautia hansenii co-metabolize the drug Nevirapine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[59], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Blautia hansenii co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Oxaprozin |
Click to Show/Hide the Detail |
| Drug ID |
DR1212
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Blautia hansenii co-metabolize the drug Oxaprozin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Rosuvastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR1445
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Blautia hansenii co-metabolize the drug Rosuvastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[43], [2] |
| Sildenafil citrate |
Click to Show/Hide the Detail |
| Drug ID |
DR1481
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Blautia hansenii co-metabolize the drug Sildenafil citrate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Blautia hansenii co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Tolazamide |
Click to Show/Hide the Detail |
| Drug ID |
DR1611
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Blautia hansenii co-metabolize the drug Tolazamide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Blautia luti (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Blautia luti co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Clostridioides difficile (firmicutes) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| Acetaminophen |
Click to Show/Hide the Detail |
| Drug ID |
DR0037
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Clostridioides difficile co-metabolize the drug Acetaminophen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [60] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Clostridioides difficile co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Clostridioides difficile co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Sildenafil citrate |
Click to Show/Hide the Detail |
| Drug ID |
DR1481
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Clostridioides difficile co-metabolize the drug Sildenafil citrate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Clostridium botulinum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 13 Drugs Metabolized
|
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Clostridium botulinum co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[27], [2] |
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Clostridium botulinum co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [2] |
| Doxazosin |
Click to Show/Hide the Detail |
| Drug ID |
DR0542
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Clostridium botulinum co-metabolize the drug Doxazosin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[31], [2] |
| Duloxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0554
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Clostridium botulinum co-metabolize the drug Duloxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[28], [2] |
| Fluconazole |
Click to Show/Hide the Detail |
| Drug ID |
DR0704
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Clostridium botulinum co-metabolize the drug Fluconazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[32], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Clostridium botulinum co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Nateglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1132
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Clostridium botulinum co-metabolize the drug Nateglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[37], [2] |
| Nevirapine |
Click to Show/Hide the Detail |
| Drug ID |
DR1142
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Clostridium botulinum co-metabolize the drug Nevirapine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[59], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Clostridium botulinum co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Oxaprozin |
Click to Show/Hide the Detail |
| Drug ID |
DR1212
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Clostridium botulinum co-metabolize the drug Oxaprozin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Sildenafil citrate |
Click to Show/Hide the Detail |
| Drug ID |
DR1481
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Clostridium botulinum co-metabolize the drug Sildenafil citrate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Clostridium botulinum co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Tolazamide |
Click to Show/Hide the Detail |
| Drug ID |
DR1611
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Clostridium botulinum co-metabolize the drug Tolazamide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Clostridium perfringens (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Metronidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1073
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Clostridium perfringens co-metabolize the drug Metronidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [61] |
| Metronidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1073
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Clostridium perfringens co-metabolize the drug Metronidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [61] |
| Clostridium scindens (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Clostridium scindens co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Clostridium scindens co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Clostridium spiroforme (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Clostridium spiroforme co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Clostridium spiroforme co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Clostridium sporogenes (firmicutes) |
Click to Show/Hide the Full List of Drugs: 5 Drugs Metabolized
|
| Carvedilol |
Click to Show/Hide the Detail |
| Drug ID |
DR0282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Clostridium sporogenes co-metabolize the drug Carvedilol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[26], [2] |
| Celecoxib |
Click to Show/Hide the Detail |
| Drug ID |
DR0286
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Clostridium sporogenes co-metabolize the drug Celecoxib, which can collectively affect efficacy, safety or bioavailability of this drug. |
[42], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Clostridium sporogenes co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[27], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Clostridium sporogenes co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Clostridium sporogenes co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Clostridium symbiosum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Clostridium symbiosum co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Clostridium symbiosum co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Coprococcus comes (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Coprococcus comes co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Coprococcus comes co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Dorea formicigenerans (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Dorea formicigenerans co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Dorea formicigenerans co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Dorea formicigenerans co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Enterocloster asparagiformis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Enterocloster asparagiformis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Enterocloster asparagiformis co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Enterocloster bolteae (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Enterocloster bolteae co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Enterocloster bolteae co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Enterocloster bolteae co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Enterococcus casseliflavus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Metronidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1073
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Enterococcus casseliflavus co-metabolize the drug Metronidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [62] |
| Enterococcus faecalis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Acetaminophen |
Click to Show/Hide the Detail |
| Drug ID |
DR0037
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Enterococcus faecalis co-metabolize the drug Acetaminophen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [60] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Enterococcus faecalis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Enterococcus faecalis co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Enterococcus gallinarum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Metronidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1073
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Enterococcus gallinarum co-metabolize the drug Metronidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [62] |
| Erysipelatoclostridium ramosum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Erysipelatoclostridium ramosum co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Indomethacin |
Click to Show/Hide the Detail |
| Drug ID |
DR0875
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) metabolizes the drug Indomethacin, and Erysipelatoclostridium ramosum further metabolizes its metabolite (Indomethacin glucuronide), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[5], [47] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Erysipelatoclostridium ramosum co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Eubacterium rectale (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Eubacterium rectale co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Eubacterium rectale co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Eubacterium ventriosum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Eubacterium ventriosum co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Eubacterium ventriosum co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Eubacterium ventriosum co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Faecalibacterium prausnitzii (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Diclofenac sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR0488
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) metabolizes the drug Diclofenac sodium, and Faecalibacterium prausnitzii further metabolizes its metabolite (Diclofenac glucuronide), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[20], [30] |
| Holdemanella biformis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 7 Drugs Metabolized
|
| Carvedilol |
Click to Show/Hide the Detail |
| Drug ID |
DR0282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Holdemanella biformis co-metabolize the drug Carvedilol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[26], [2] |
| Celecoxib |
Click to Show/Hide the Detail |
| Drug ID |
DR0286
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Holdemanella biformis co-metabolize the drug Celecoxib, which can collectively affect efficacy, safety or bioavailability of this drug. |
[42], [2] |
| Cyclophosphamide |
Click to Show/Hide the Detail |
| Drug ID |
DR0391
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Holdemanella biformis co-metabolize the drug Cyclophosphamide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Holdemanella biformis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Glipizide |
Click to Show/Hide the Detail |
| Drug ID |
DR0778
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Holdemanella biformis co-metabolize the drug Glipizide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[29], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Holdemanella biformis co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Tolazamide |
Click to Show/Hide the Detail |
| Drug ID |
DR1611
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Holdemanella biformis co-metabolize the drug Tolazamide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Hungatella hathewayi (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Hungatella hathewayi co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Hungatella hathewayi co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Jeotgalicoccus psychrophilus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Aspirin |
Click to Show/Hide the Detail |
| Drug ID |
DR1749
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Jeotgalicoccus psychrophilus co-metabolize the drug Aspirin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[51], [52] |
| Lactobacillus reuteri (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Lactobacillus reuteri co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Lactobacillus reuteri co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Lactobacillus rhamnosus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Diclofenac sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR0488
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) metabolizes the drug Diclofenac sodium, and Lactobacillus rhamnosus further metabolizes its metabolite (Diclofenac glucuronide), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[20], [30] |
| Marvinbryantia formatexigens (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Marvinbryantia formatexigens co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Roseburia hominis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Indomethacin |
Click to Show/Hide the Detail |
| Drug ID |
DR0875
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) metabolizes the drug Indomethacin, and Roseburia hominis further metabolizes its metabolite (Indomethacin glucuronide), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[5], [47] |
| Roseburia intestinalis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 5 Drugs Metabolized
|
| Carvedilol |
Click to Show/Hide the Detail |
| Drug ID |
DR0282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Roseburia intestinalis co-metabolize the drug Carvedilol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[26], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Roseburia intestinalis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Indomethacin |
Click to Show/Hide the Detail |
| Drug ID |
DR0875
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) metabolizes the drug Indomethacin, and Roseburia intestinalis further metabolizes its metabolite (Indomethacin glucuronide), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[5], [47] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Roseburia intestinalis co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Roseburia intestinalis co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Ruminococcus albus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Aspirin |
Click to Show/Hide the Detail |
| Drug ID |
DR1749
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Ruminococcus albus co-metabolize the drug Aspirin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[51], [52] |
| Ruminococcus gnavus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| Diclofenac sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR0488
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) metabolizes the drug Diclofenac sodium, and Ruminococcus gnavus further metabolizes its metabolite (Diclofenac glucuronide), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[20], [30] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Ruminococcus gnavus co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Ruminococcus gnavus co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Ruminococcus gnavus co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Ruminococcus lactaris (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Ruminococcus lactaris co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Ruminococcus lactaris co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Ruminococcus lactaris co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Ruminococcus torques (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Ruminococcus torques co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Subdoligranulum variabile (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Subdoligranulum variabile co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Subdoligranulum variabile co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bacteria: Lentisphaerae |
|---|
| Victivallis vadensis (PVC bacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Victivallis vadensis co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Victivallis vadensis co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bacteria: Proteobacteria |
|---|
| Citrobacter freundii (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Acetaminophen |
Click to Show/Hide the Detail |
| Drug ID |
DR0037
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Citrobacter freundii co-metabolize the drug Acetaminophen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [60] |
| Edwardsiella tarda (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Edwardsiella tarda co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Edwardsiella tarda co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Enterobacter cancerogenus (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| Duloxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0554
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Enterobacter cancerogenus co-metabolize the drug Duloxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[28], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Enterobacter cancerogenus co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Enterobacter cancerogenus co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Enterobacter cancerogenus co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Enterobacter cloacae (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Metronidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1073
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Enterobacter cloacae co-metabolize the drug Metronidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [63] |
| Escherichia coli (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 8 Drugs Metabolized
|
| Acetaminophen |
Click to Show/Hide the Detail |
| Drug ID |
DR0037
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Escherichia coli co-metabolize the drug Acetaminophen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [60] |
| Bupropion |
Click to Show/Hide the Detail |
| Drug ID |
DR0247
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Escherichia coli co-metabolize the drug Bupropion, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Duloxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0554
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Escherichia coli co-metabolize the drug Duloxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[28], [2] |
| Flunitrazepam |
Click to Show/Hide the Detail |
| Drug ID |
DR0712
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Escherichia coli co-metabolize the drug Flunitrazepam, which can collectively affect efficacy, safety or bioavailability of this drug. |
[64], [65] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Escherichia coli co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Indomethacin |
Click to Show/Hide the Detail |
| Drug ID |
DR0875
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) metabolizes the drug Indomethacin, and Escherichia coli further metabolizes its metabolite (Indomethacin glucuronide), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[5], [66] |
| Ketoprofen |
Click to Show/Hide the Detail |
| Drug ID |
DR0907
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) metabolizes the drug Ketoprofen, and Escherichia coli further metabolizes its metabolite (Ketoprofen glucuronide), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[67], [68] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Escherichia coli co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Helicobacter apodemus (epsilon-proteobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Aspirin |
Click to Show/Hide the Detail |
| Drug ID |
DR1749
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Helicobacter apodemus co-metabolize the drug Aspirin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[51], [52] |
| Proteus penneri (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Proteus penneri co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Proteus penneri co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Proteus penneri co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Providencia alcalifaciens (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Providencia alcalifaciens co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Providencia rettgeri (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Providencia rettgeri co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Providencia stuartii (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Providencia stuartii co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Providencia stuartii co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Providencia stuartii co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Pseudomonas putida (gamma-proteobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Nicotine |
Click to Show/Hide the Detail |
| Drug ID |
DR1148
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Pseudomonas putida co-metabolize the drug Nicotine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[69], [70] |
| Ralstonia solanacearum (beta-proteobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| ANW-43703 |
Click to Show/Hide the Detail |
| Drug ID |
DR1458
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Ralstonia solanacearum co-metabolize the drug ANW-43703, which can collectively affect efficacy, safety or bioavailability of this drug. |
[71], [72], [73] |
| Salmonella enterica (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Salmonella enterica co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Salmonella enterica co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Salmonella typhimurium (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Niclosamide |
Click to Show/Hide the Detail |
| Drug ID |
DR1146
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Salmonella typhimurium co-metabolize the drug Niclosamide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[74], [75] |
| Shewanella oneidensis (gamma-proteobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Sulfamethoxazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1511
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Shewanella oneidensis co-metabolize the drug Sulfamethoxazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[76], [77], [78] |
| Sphingomonas colocasiae (alpha-proteobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Ibuprofen |
Click to Show/Hide the Detail |
| Drug ID |
DR0844
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Sphingomonas colocasiae co-metabolize the drug Ibuprofen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [79] |
| Bacteria: Synergistetes |
|---|
| Synergistetes bacterium (synergistetes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Sulfamethoxazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1511
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Synergistetes bacterium co-metabolize the drug Sulfamethoxazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[76], [80], [81] |
| Bacteria: Verrucomicrobia |
|---|
| Akkermansia muciniphila (verrucomicrobiae) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Naftopidil |
Click to Show/Hide the Detail |
| Drug ID |
DR1124
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Akkermansia muciniphila co-metabolize the drug Naftopidil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[41], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Akkermansia muciniphila co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Fungi: Ascomycota |
|---|
| Saccharomyces cerevisiae (ascomycota) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Acetaminophen |
Click to Show/Hide the Detail |
| Drug ID |
DR0037
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) metabolizes the drug Acetaminophen, and Saccharomyces cerevisiae further metabolizes its metabolite (1-Phenyl-1,2-propanedione), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[11], [60] |
| Archaea: Euryarchaeota |
|---|
| Methanobrevibacter oralis (methanobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Rifampicin |
Click to Show/Hide the Detail |
| Drug ID |
DR1420
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Methanobrevibacter oralis co-metabolize the drug Rifampicin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [82] |
| Methanobrevibacter smithii (methanobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Rifampicin |
Click to Show/Hide the Detail |
| Drug ID |
DR1420
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Methanobrevibacter smithii co-metabolize the drug Rifampicin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [82] |
| Methanomassiliicoccus luminyensis (thermoplasmata) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Rifampicin |
Click to Show/Hide the Detail |
| Drug ID |
DR1420
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Methanomassiliicoccus luminyensis co-metabolize the drug Rifampicin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [82] |
| Methanosphaera stadtmanae (methanobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Rifampicin |
Click to Show/Hide the Detail |
| Drug ID |
DR1420
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Methanosphaera stadtmanae co-metabolize the drug Rifampicin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [82] |
| Amoebozoa: Evosea |
|---|
| Entamoeba histolytica (eukaryotes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Metronidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1073
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Entamoeba histolytica co-metabolize the drug Metronidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [83] |
| Metamonada: Fornicata |
|---|
| Giardia intestinalis (diplomonads) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Metronidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1073
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Giardia intestinalis co-metabolize the drug Metronidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [83] |
| Metamonada: Parabasalia |
|---|
| Trichomonas vaginalis (trichomonads) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Metronidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1073
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C9 (CYP2C9) and Trichomonas vaginalis co-metabolize the drug Metronidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [83] |
|
|
|
|
|
|
